Remdesivir Completed Phase 4 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT05502081 | Clinical Study to Compare Efficacy and Safety of Casirivimab and Imdevimab Combination, Remdesivir and Favipravir in Hospitalized COVID-19 Patients |